ARCHIVES

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

This article is from The Cancer Letter archive.

Vol. 04 No. 16 | April 21, 1978

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Richard Pestell To Lead Lombardi Cancer Cente

September 6, 2002

AAAS Urges Bush To Continue Funding For Stem Cell Research; ONS Hires Arent Fox.

March 9, 2001

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001